ClinicalTrials.govpublic full text
Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination
diphtheria, tetanus, whooping cough, hepatitis b, poliomyelitis, haemophilus influenzae type b, pediatric combined vaccine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858786
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.